# Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

> **NCT00050973** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 623 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** bexarotene

## Key facts

- **NCT ID:** NCT00050973
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2004-11
- **Final completion:** 2005-03
- **Target enrollment:** 623 (ACTUAL)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050973, "Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00050973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*